Literature DB >> 15031527

Toll-like receptor 3: a link between toll-like receptor, interferon and viruses.

Misako Matsumoto1, Kenji Funami, Hiroyuki Oshiumi, Tsukasa Seya.   

Abstract

Production of type I interferon (IFN-alpha/beta) by virus-infected cells is the central event in their antiviral immune responses. In mammalian cells, IFN-alpha/beta gene transcription is induced through distinct signaling pathways by viral infection or by treatment with double-stranded (ds) RNA, which is an intermediate of virus replication. Toll-like receptor 3 (TLR3) was found to recognize dsRNA and transmit signals to activate NF-kappaB and the IFN-beta promoter. Recent identification of the TLR3-adaptor protein and its downstream signaling molecules, which are involved in IFN-alpha/beta production, revealed a novel IFN-inducing pathway for an anti-viral immune response. Here, we summarize the current knowledge of TLR3-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031527     DOI: 10.1111/j.1348-0421.2004.tb03500.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  59 in total

1.  The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Hum Genet       Date:  2011-03-19       Impact factor: 4.132

2.  Double-stranded RNA induces sequence-specific antiviral silencing in addition to nonspecific immunity in a marine shrimp: convergence of RNA interference and innate immunity in the invertebrate antiviral response?

Authors:  Javier Robalino; Thomas Bartlett; Eleanor Shepard; Sarah Prior; Guillermo Jaramillo; Edward Scura; Robert W Chapman; Paul S Gross; Craig L Browdy; Gregory W Warr
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 3.  Toll-like receptors and the eye.

Authors:  Fu-Shin X Yu; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

4.  TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.

Authors:  Thomas B Thornley; Michael A Brehm; Thomas G Markees; Leonard D Shultz; John P Mordes; Raymond M Welsh; Aldo A Rossini; Dale L Greiner
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

Review 5.  Toll-like receptors and corneal innate immunity.

Authors:  Ashok Kumar; Fu-Shin X Yu
Journal:  Curr Mol Med       Date:  2006-05       Impact factor: 2.222

6.  Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.

Authors:  Markus Wörnle; Holger Schmid; Bernhard Banas; Monika Merkle; Anna Henger; Maximilian Roeder; Simone Blattner; Elisabeth Bock; Matthias Kretzler; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 7.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

Authors:  Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

Review 8.  Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Authors:  Okom Nkili F C Ofodile
Journal:  J Ind Microbiol Biotechnol       Date:  2007-09-05       Impact factor: 3.346

9.  Differential expression of toll-like receptors in the human placenta across early gestation.

Authors:  Jeffrey Pudney; Xianbao He; Zahrah Masheeb; David W Kindelberger; Wendy Kuohung; Robin R Ingalls
Journal:  Placenta       Date:  2016-07-26       Impact factor: 3.481

Review 10.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.